Persistent gamma-globin expression in adult transgenic mice is mediated by HPFH-2, HPFH-3, and HPFH-6 breakpoint sequences.

Abstract:

:Deletions at the 3' end of the human beta-globin locus are associated with the hereditary persistence of fetal hemoglobin (HPFH) in adults, potentially through the juxtaposition of enhancer elements in the vicinity of the fetal gamma-globin genes. We have tested how sequences at the HPFH-2, HPFH-3, and HPFH-6 breakpoints, which act as enhancers in vitro, affect the silencing of a locus control region A gamma (LCRA gamma) transgene in the adult stage of mice. We found persistent A gamma expression in the adult blood of most of the multicopy HPFH-2, HPFH-3, or HPFH-6 lines, in contrast to the control LCRA gamma lines which were silenced. Cre-mediated generation of single copy lines showed persistent gamma gene expression maintained in some of the HPFH-2 and HPFH-6 lines, but not in any of the HPFH-3 or LCRA gamma lines. In the HPFH-2 and HPFH-6 lines, persistent gamma gene expression correlated with euchromatic transgene integrations. Thus, our observations provide support for a model whereby HPFH conditions arise from the juxtaposition of enhancers as well as permissive chromatin subdomains in the vicinity of the gamma-globin genes.

journal_name

Blood

journal_title

Blood

authors

Katsantoni EZ,Langeveld A,Wai AW,Drabek D,Grosveld F,Anagnou NP,Strouboulis J

doi

10.1182/blood-2003-05-1681

subject

Has Abstract

pub_date

2003-11-01 00:00:00

pages

3412-9

issue

9

eissn

0006-4971

issn

1528-0020

pii

2003-05-1681

journal_volume

102

pub_type

杂志文章

相关文献

BLOOD文献大全
  • NF-kappaB as a target for the prevention of graft-versus-host disease: comparative efficacy of bortezomib and PS-1145.

    abstract::NF-kappaB is a transcription factor that controls the expression of a number of genes important for mediating immune and inflammatory responses. In this study, we examined whether bortezomib and PS-1145, each of which inhibits NF-kappaB, could protect mice from lethal graft-versus-host disease (GVHD), which is charact...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-05-1820

    authors: Vodanovic-Jankovic S,Hari P,Jacobs P,Komorowski R,Drobyski WR

    更新日期:2006-01-15 00:00:00

  • Normal T-cell telomerase activity and upregulation in human immunodeficiency virus-1 infection.

    abstract::In human immunodeficiency virus (HIV)-1 infection, decrease of telomere length is mainly found in CD8(+) T cells and not in CD4(+) T cells. Telomerase, a ribonucleoprotein enzyme that can synthesize telomeric sequence onto chromosomal ends, can compensate for telomere loss. Here, we investigated if telomerase activity...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Wolthers KC,Otto SA,Wisman GB,Fleury S,Reiss P,ten Kate RW,van der Zee AG,Miedema F

    更新日期:1999-02-01 00:00:00

  • Enzymatic treatment of long-term human marrow cultures reveals the preferential location of primitive hemopoietic progenitors in the adherent layer.

    abstract::Recent studies with long-term mouse marrow cultures have indicated the importance of the adherent layer as a primary reservoir of the most primitive stem cells, from which derivative stem cells and more differentiated progenitors are continuously generated. We have now examined the role of the adherent cell layer in l...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Coulombel L,Eaves AC,Eaves CJ

    更新日期:1983-08-01 00:00:00

  • Correction of the platelet adhesion defect in delta-storage pool deficiency at elevated hematocrit--possible role of adenosine diphosphate.

    abstract::Previous studies on patients with storage pool deficiency (SPD) who are specifically deficient in platelet dense granules (delta-SPD) have suggested a role for dense granule substances, in all likelihood adenosine diphosphate (ADP), in mediating thrombus formation on subendothelium at high shear rates. The role of den...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Weiss HJ,Lages B,Hoffmann T,Turitto VT

    更新日期:1996-05-15 00:00:00

  • Antigenic modulation limits the efficacy of anti-CD20 antibodies: implications for antibody selection.

    abstract::Rituximab, a monoclonal antibody that targets CD20 on B cells, is now central to the treatment of a variety of malignant and autoimmune disorders. Despite this success, a substantial proportion of B-cell lymphomas are unresponsive or develop resistance, hence more potent anti-CD20 monoclonal antibodies (mAbs) are cont...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-01-263533

    authors: Beers SA,French RR,Chan HT,Lim SH,Jarrett TC,Vidal RM,Wijayaweera SS,Dixon SV,Kim H,Cox KL,Kerr JP,Johnston DA,Johnson PW,Verbeek JS,Glennie MJ,Cragg MS

    更新日期:2010-06-24 00:00:00

  • Induction of fibrinogen binding and platelet aggregation as a potential intrinsic property of various glycoprotein IIb/IIIa (alphaIIbbeta3) inhibitors.

    abstract::The blockade of platelet integrin glycoprotein (GP) IIb/IIIa is a promising new antiplatelet strategy. The binding of ligands or of the ligand-mimetic peptide RGD causes a conformational change of GP IIb/IIIa from the nonactivated to the activated state. Because several blocking agents/inhibitors are ligand-mimetics, ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Peter K,Schwarz M,Ylänne J,Kohler B,Moser M,Nordt T,Salbach P,Kübler W,Bode C

    更新日期:1998-11-01 00:00:00

  • Reversible skeletal disease and high fluoride serum levels in hematologic patients receiving voriconazole.

    abstract::We here investigate the occurrence of fluoride intake-associated alterations in patients with hematologic disease on triazol antifungal medication. Clinical, laboratory, and radiology data of overall 43 patients with hematologic malignancies taking voriconazole (n = 20), posaconazole (n = 8), and itraconazole (n = 4),...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-01-403030

    authors: Gerber B,Guggenberger R,Fasler D,Nair G,Manz MG,Stussi G,Schanz U

    更新日期:2012-09-20 00:00:00

  • Molecular and functional analysis of the stem cell compartment of chronic myelogenous leukemia reveals the presence of a CD34- cell population with intrinsic resistance to imatinib.

    abstract::We show the molecular and functional characterization of a novel population of lineage-negative CD34-negative (Lin(-)CD34(-)) hematopoietic stem cells from chronic myelogenous leukemia (CML) patients at diagnosis. Molecular karyotyping and quantitative analysis of BCR-ABL transcript demonstrated that approximately one...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-08-176016

    authors: Lemoli RM,Salvestrini V,Bianchi E,Bertolini F,Fogli M,Amabile M,Tafuri A,Salati S,Zini R,Testoni N,Rabascio C,Rossi L,Martin-Padura I,Castagnetti F,Marighetti P,Martinelli G,Baccarani M,Ferrari S,Manfredini R

    更新日期:2009-12-10 00:00:00

  • Assessment of mechanism of acquired skewed X inactivation by analysis of twins.

    abstract::Skewed X-chromosome inactivation in peripheral blood granulocytes becomes more frequent with increasing age, affecting up to half of those over 75 years old. To investigate the mechanisms underlying this phenomenon, X-inactivation profiles in 33 monozygotic and 22 dizygotic elderly twin pairs were studied. Differentia...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v97.5.1274

    authors: Vickers MA,McLeod E,Spector TD,Wilson IJ

    更新日期:2001-03-01 00:00:00

  • Identification of novel therapeutic targets in acute leukemias with NRAS mutations using a pharmacologic approach.

    abstract::Oncogenic forms of NRAS are frequently associated with hematologic malignancies and other cancers, making them important therapeutic targets. Inhibition of individual downstream effector molecules (eg, RAF kinase) have been complicated by the rapid development of resistance or activation of bypass pathways. For the pu...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-12-615906

    authors: Nonami A,Sattler M,Weisberg E,Liu Q,Zhang J,Patricelli MP,Christie AL,Saur AM,Kohl NE,Kung AL,Yoon H,Sim T,Gray NS,Griffin JD

    更新日期:2015-05-14 00:00:00

  • A case-control study to assess the risk of immune thrombocytopenia associated with vaccines.

    abstract::The cause of immune thrombocytopenia (ITP) remains unknown. Studies have suggested immunizations as possible triggering factors of ITP through molecular mimicry. This case-control study explored potential associations between adult ITP and various routinely administered vaccines. A network of internal medicine and hem...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1182/blood-2012-05-431098

    authors: Grimaldi-Bensouda L,Michel M,Aubrun E,Leighton P,Viallard JF,Adoue D,Magy-Bertrand N,Tisserand G,Khellaf M,Durand JM,Quittet P,Fain O,Bonnotte B,Morin AS,Limal N,Costedoat-Chalumeau N,Morel N,Pan-Petesch B,Decaux O,

    更新日期:2012-12-13 00:00:00

  • Bone marrow contains virus-specific cytotoxic T lymphocytes.

    abstract::Immunizing bone marrow donors prior to bone marrow transplant (BMT) has the potential for adoptively transferring specific immunity against opportunistic pathogens. Studies have shown that long-term antibody production occurs in the bone marrow and that specific humoral immunity may be transferred from donor to recipi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Slifka MK,Whitmire JK,Ahmed R

    更新日期:1997-09-01 00:00:00

  • CD34+ marrow cells, devoid of T and B lymphocytes, reconstitute stable lymphopoiesis and myelopoiesis in lethally irradiated allogeneic baboons.

    abstract::CD34+ cells devoid of detectable mature and immature T and B lymphocytes, expressing the CD2, CD10, and CD20 antigens, were isolated from marrows of three pairs of sex-mismatched, mixed lymphocyte culture (MLC) nonreactive, sibling baboons. Reciprocal transplants were performed between members of each pair, using the ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Andrews RG,Bryant EM,Bartelmez SH,Muirhead DY,Knitter GH,Bensinger W,Strong DM,Bernstein ID

    更新日期:1992-10-01 00:00:00

  • Expansion of EBNA1-specific effector T cells in posttransplantation lymphoproliferative disorders.

    abstract::Immunosuppression resulting in impaired Epstein-Barr virus (EBV)-specific T-cell immunity is involved in the pathogenesis of EBV-positive post-transplantation lymphoproliferative disorder (EBV(+) PTLD). Restoration of EBV-specific T-cell immunity by adoptive immunotherapy can induce remission. EBV-nuclear antigen-1 (E...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-03-274076

    authors: Jones K,Nourse JP,Morrison L,Nguyen-Van D,Moss DJ,Burrows SR,Gandhi MK

    更新日期:2010-09-30 00:00:00

  • Platelet microRNA-mRNA coexpression profiles correlate with platelet reactivity.

    abstract::MicroRNAs (miRNAs) regulate cell physiology by altering protein expression, but the biology of platelet miRNAs is largely unexplored. We tested whether platelet miRNA levels were associated with platelet reactivity by genome-wide profiling using platelet RNA from 19 healthy subjects. We found that human platelets expr...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-09-299719

    authors: Nagalla S,Shaw C,Kong X,Kondkar AA,Edelstein LC,Ma L,Chen J,McKnight GS,López JA,Yang L,Jin Y,Bray MS,Leal SM,Dong JF,Bray PF

    更新日期:2011-05-12 00:00:00

  • Perforin deficiency impairs a critical immunoregulatory loop involving murine CD8(+) T cells and dendritic cells.

    abstract::Humans and mice with impaired perforin-dependent cytotoxic function may develop excessive T-cell activation and the fatal disorder hemophagocytic lymphohistiocytosis (HLH) after infection. Though cytotoxic lymphocytes can kill antigen-presenting cells, the physiological mechanism of perforin-mediated immune regulation...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2013-04-495309

    authors: Terrell CE,Jordan MB

    更新日期:2013-06-27 00:00:00

  • 2-Chlorodeoxyadenosine: an active agent in the treatment of cutaneous T-cell lymphoma.

    abstract::Cutaneous T-cell lymphomas are disfiguring malignant lymphoproliferative disorders for which standard therapy has been principally palliative. 2-Chlorodeoxyadenosine (2-CdA), a new purine analogue resistant to degradation by adenosine deaminase that has substantial activity against lymphoid neoplasms, was administered...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Saven A,Carrera CJ,Carson DA,Beutler E,Piro LD

    更新日期:1992-08-01 00:00:00

  • Synergy between imatinib and mycophenolic acid in inducing apoptosis in cell lines expressing Bcr-Abl.

    abstract::Bcr-Abl tyrosine kinase activity initiates a number of intracellular signaling cascades that result in leukemogenesis. Imatinib mesylate, a specific Bcr-Abl tyrosine kinase inhibitor, has been highly successful in the treatment of chronic myelogenous leukemia (CML). However, the emergence of imatinib resistance and th...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-10-3864

    authors: Gu JJ,Santiago L,Mitchell BS

    更新日期:2005-04-15 00:00:00

  • Discussing and managing hematologic germ line variants.

    abstract::With the introduction of genomic technologies, more hereditary cancer syndromes with hematologic malignancies are being described. Up to 10% of hematologic malignancies in children and adults may be the result of an underlying inherited genetic risk. Managing these patients with hereditary hematologic malignancies, in...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2016-06-716704

    authors: Kohlmann W,Schiffman JD

    更新日期:2016-11-24 00:00:00

  • Functional involvement of Akt signaling downstream of Jak1 in v-Abl-induced activation of hematopoietic cells.

    abstract::Activation of intracellular signaling pathways is important for cellular transformation and tumorigenesis. The nonreceptor tyrosine kinases Jak1 and Jak3, which bind to the v-Abl oncoprotein, are constitutively activated in cells transformed with the Abelson murine leukemia virus. A mutant of p160 v-Abl lacking the Ja...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v100.3.966

    authors: Oki S,Limnander A,Danial NN,Rothman PB

    更新日期:2002-08-01 00:00:00

  • Bcl-2 protein expression is the strongest independent prognostic factor of survival in primary cutaneous large B-cell lymphomas.

    abstract::Bcl-2 protein expression has been associated with poor prognosis in patients with noncutaneous diffuse large B-cell lymphomas. In primary cutaneous large B-cell lymphomas, the location on the leg, the round-cell morphology defined as the predominance of centroblasts and immunoblasts over large centrocytes, and multipl...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究

    doi:10.1182/blood-2003-08-2726

    authors: Grange F,Petrella T,Beylot-Barry M,Joly P,D'Incan M,Delaunay M,Machet L,Avril MF,Dalac S,Bernard P,Carlotti A,Esteve E,Vergier B,Dechelotte P,Cassagnau E,Courville P,Saiag P,Laroche L,Bagot M,Wechsler J

    更新日期:2004-05-15 00:00:00

  • Identification of a critical regulatory site in the human interleukin-3 promoter by in vivo footprinting.

    abstract::Interleukin-3 (IL-3) is involved in proliferation and differentiation of hematopoietic progenitor cells. Its expression is subject to precise, tissue-specific regulation, and has been studied extensively in the gibbon T-cell line MLA 144 by a combination of functional assays and DNA binding experiments. To extend thes...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Cameron S,Taylor DS,TePas EC,Speck NA,Mathey-Prevot B

    更新日期:1994-05-15 00:00:00

  • Infants with acute lymphoblastic leukemia and a germline MLL gene are highly curable with use of chemotherapy alone: results from the Japan Infant Leukemia Study Group.

    abstract::Although infants with acute lymphoblastic leukemia (ALL) and a germline MLL gene have a better prognosis than comparable infants with a rearranged MLL gene, their optimal therapy is controversial. In 2 consecutive studies, conducted between 1996 and 2002, we treated 22 cases of infant ALL with germline MLL using chemo...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1182/blood-2005-11-4728

    authors: Nagayama J,Tomizawa D,Koh K,Nagatoshi Y,Hotta N,Kishimoto T,Takahashi Y,Kuno T,Sugita K,Sato T,Kato K,Ogawa A,Nakahata T,Mizutani S,Horibe K,Ishii E,Japan Infant Leukemia Study Group.

    更新日期:2006-06-15 00:00:00

  • Cytomorphologic, immunohistochemical, and cytogenetic profiles of follicular lymphoma: 2 types of follicular lymphoma grade 3.

    abstract::Follicular lymphoma (FL) grades 1 and 2 are regarded as a distinct disease entity, whereas data suggest that FL grade 3 might be an inhomogeneous tumor category. To define the biologic spectrum of FL, 89 follicular lymphomas were studied for their cytologic composition, antigen expression, mitotic and proliferation in...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v99.10.3806

    authors: Ott G,Katzenberger T,Lohr A,Kindelberger S,Rüdiger T,Wilhelm M,Kalla J,Rosenwald A,Müller JG,Ott MM,Müller-Hermelink HK

    更新日期:2002-05-15 00:00:00

  • Role of cytokines in leukemic type growth of myelodysplastic CD34+ cells.

    abstract::The clonal growth of progenitor cells from myelodysplastic syndromes (MDS) can be subdivided into four growth patterns: (1) normal, (2) no growth or low plating efficiency, (3) low colony and high cluster number, and (4) normal or high colony number with a large number of clusters. The former two (1 and 2) can be refe...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Sawada K,Ieko M,Notoya A,Tarumi T,Koizumi K,Kitayama S,Nishio H,Fukada Y,Yasukouchi T,Yamaguchi M,Katoh S,Koike T

    更新日期:1996-07-01 00:00:00

  • Randomized phase 2 study of low-dose decitabine vs low-dose azacitidine in lower-risk MDS and MDS/MPN.

    abstract::Hypomethylating agents (HMAs) improve survival in patients with higher-risk myelodysplastic syndromes (MDS) but are less well-studied in lower-risk disease. We compared the safety and efficacy of low-dose decitabine vs low-dose azacitidine in this group of patients. Adults with low- or intermediate 1-risk MDS or MDS/m...

    journal_title:Blood

    pub_type: 杂志文章,随机对照试验

    doi:10.1182/blood-2017-06-788497

    authors: Jabbour E,Short NJ,Montalban-Bravo G,Huang X,Bueso-Ramos C,Qiao W,Yang H,Zhao C,Kadia T,Borthakur G,Pemmaraju N,Sasaki K,Estrov Z,Cortes J,Ravandi F,Alvarado Y,Komrokji R,Sekeres MA,Steensma DP,DeZern A,Roboz G,

    更新日期:2017-09-28 00:00:00

  • Molecular cloning of a cDNA encoding canine factor IX.

    abstract::Factor IX (F.IX) is a vitamin K-dependent plasma protein, a deficiency of which results in hemophilia B. A canine model of hemophilia B exists; attempts to use this model for gene transfer experiments or characterization of the hemophilic defect require elucidation of normal canine F.IX structure. We report the isolat...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Evans JP,Watzke HH,Ware JL,Stafford DW,High KA

    更新日期:1989-07-01 00:00:00

  • An RNAi therapeutic targeting Tmprss6 decreases iron overload in Hfe(-/-) mice and ameliorates anemia and iron overload in murine β-thalassemia intermedia.

    abstract::Mutations in HFE lead to hereditary hemochromatosis (HH) because of inappropriately high iron uptake from the diet resulting from decreased hepatic expression of the iron-regulatory hormone hepcidin. -thalassemia is a congenital anemia caused by partial or complete loss of -globin synthesis causing ineffective erythro...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-09-453977

    authors: Schmidt PJ,Toudjarska I,Sendamarai AK,Racie T,Milstein S,Bettencourt BR,Hettinger J,Bumcrot D,Fleming MD

    更新日期:2013-02-14 00:00:00

  • Acquisition of a CD19-negative myeloid phenotype allows immune escape of MLL-rearranged B-ALL from CD19 CAR-T-cell therapy.

    abstract::Administration of lymphodepletion chemotherapy followed by CD19-specific chimeric antigen receptor (CAR)-modified T cells is a remarkably effective approach to treating patients with relapsed and refractory CD19(+) B-cell malignancies. We treated 7 patients with B-cell acute lymphoblastic leukemia (B-ALL) harboring re...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2015-08-665547

    authors: Gardner R,Wu D,Cherian S,Fang M,Hanafi LA,Finney O,Smithers H,Jensen MC,Riddell SR,Maloney DG,Turtle CJ

    更新日期:2016-05-19 00:00:00

  • Acquired FANCA dysfunction and cytogenetic instability in adult acute myelogenous leukemia.

    abstract::Myelodysplastic and leukemic stem cell clones that evolve in children and adults with Fanconi anemia universally bear complex cytogenetic abnormalities. The abnormalities are generally recurring deletions or chromosomal loss and involve precisely the same chromosomes with the same frequency as has been described in ma...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-09-2781

    authors: Lensch MW,Tischkowitz M,Christianson TA,Reifsteck CA,Speckhart SA,Jakobs PM,O'Dwyer ME,Olson SB,Le Beau MM,Hodgson SV,Mathew CG,Larson RA,Bagby GC Jr

    更新日期:2003-07-01 00:00:00